Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johns Hopkins
Biotech
Third Rock, Novo Holdings-backed Clasp hooks $150M series A
A new immuno-oncology biotech has emerged, clasping $150 million that will go toward developing next-gen T cell engagers.
Gabrielle Masson
Mar 20, 2024 7:00am
GSK identifies bacterium with malaria-fighting potential
Aug 7, 2023 3:10pm
Novartis' Jakavi has repurposing potential in heart arrhythmia
Jun 27, 2023 11:30am
Heart-on-a-chip experiments blast off to the ISS
Mar 13, 2023 9:50am
Scientists make the case for 'intelligent' organoids in research
Mar 7, 2023 10:50am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am